Your browser doesn't support javascript.
loading
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Corren, Jonathan; Castro, Mario; O'Riordan, Thomas; Hanania, Nicola A; Pavord, Ian D; Quirce, Santiago; Chipps, Bradley E; Wenzel, Sally E; Thangavelu, Karthinathan; Rice, Megan S; Harel, Sivan; Jagerschmidt, Alexandre; Khan, Asif H; Kamat, Siddhesh; Maroni, Jaman; Rowe, Paul; Lu, Yufang; Amin, Nikhil; Pirozzi, Gianluca; Ruddy, Marcella; Graham, Neil M H; Teper, Ariel.
Afiliación
  • Corren J; David Geffen School of Medicine at UCLA, Los Angeles, Calif. Electronic address: jcorren@ucla.edu.
  • Castro M; Washington University School of Medicine, St. Louis, Mo.
  • O'Riordan T; Sanofi, Bridgewater, NJ.
  • Hanania NA; Baylor College of Medicine, Houston, Tex.
  • Pavord ID; Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Quirce S; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Chipps BE; Capital Allergy and Respiratory Disease Center, Sacramento, Calif.
  • Wenzel SE; University of Pittsburgh Asthma Institute, Pittsburgh, Pa.
  • Thangavelu K; Sanofi, Cambridge, Mass.
  • Rice MS; Sanofi, Cambridge, Mass.
  • Harel S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Jagerschmidt A; Sanofi, Chilly-Mazarin, France.
  • Khan AH; Sanofi, Chilly-Mazarin, France.
  • Kamat S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Maroni J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Rowe P; Sanofi, Bridgewater, NJ.
  • Lu Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Amin N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Pirozzi G; Sanofi, Bridgewater, NJ.
  • Ruddy M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Graham NMH; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.
  • Teper A; Sanofi, Bridgewater, NJ.
J Allergy Clin Immunol Pract ; 8(2): 516-526, 2020 02.
Article en En | MEDLINE | ID: mdl-31521831

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2020 Tipo del documento: Article